As of March 2025 Sangamo Therapeutics has a market cap of C$0.27 Billion. This makes Sangamo Therapeutics the world's 8271th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Marketcap | Change |
---|---|---|
2025 | C$0.27 B | -64.6% |
2024 | C$0.76 B | 499.76% |
2023 | C$0.12 B | -81.7% |
2022 | C$0.69 B | -49.85% |
2021 | C$1.39 B | -50.52% |
2020 | C$2.81 B | 121.99% |
2019 | C$1.26 B | -20.67% |
2018 | C$1.59 B | -8.3% |
2017 | C$1.74 B | 502.04% |
2016 | C$0.28 B | -67.51% |
2015 | C$0.89 B | -26.9% |
2014 | C$1.21 B | 32.45% |
2013 | C$0.92 B | 190.24% |
2012 | C$0.31 B | 109.19% |
2011 | C$0.15 B | -49.67% |
2010 | C$0.30 B | 7.46% |
2009 | C$0.28 B | 61.63% |
2008 | C$0.17 B | -66.89% |
2007 | C$0.52 B | 94.46% |
2006 | C$0.26 B | 87.75% |
2005 | C$0.14 B | -21.24% |
2004 | C$0.18 B | 2.85% |
2003 | C$0.17 B | 50.55% |
2002 | C$0.11 B | -67.71% |
2001 | C$0.36 B | -43.7% |
2000 | C$0.64 B |
On Mar 25th, 2025 the market cap of Sangamo Therapeutics was reported to be: